FIRST AIRED: July 6, 2017

Nice work! Enjoy the show!


You’re busy. We get it.

Stay on top of the news with our Editor’s Picks newsletter.

US Edition
Intl. Edition
Unsubscribe at any time. One click, it’s gone.

Thanks for signing up!



>> A district court judge on Wednesday ordering outspoken pharma bro Martin Shkreli to do something his biggest critics have only dreamed of enforcing: to put a sock in it. Shkreli, who's often referred to as the most hated in America, is now barred from speaking about his fraud case in or around the Brooklyn courthouse where he's standing trial.
Reuter's Legal Correspondent, Brandon Pearson is there.>> The main thing that prompted it was that last Friday during the lunch break in his trial. Mr. Shkreli walked into a room where they were showing a digital stream of the trial to spectators and the press and sort of gave an impromptu press conference.
He criticized the prosecutors, criticized one of their witnesses. Maintained his innocence, just generally made a lot of off the cuff remarks without his lawyer there.>> Shkreli also appeared to be commenting on the case on Twitter under the handle BLMBro which is now suspended. Shkreli previously tweeted under his own name but Twitter banned him from doing so in January.
After harassing a female journalist. Shkreli's attorney opposed the gag order, saying in a court filing that his client had a First Amendment right to speak freely.>> The problem is the more Shkreli talks about the case outside of the courtroom, the more likely it is that something Shkreli says finds it's way back to one of the jurors.
Jurors are not supposed to hear anything about the case. Other than what they're presented with in the court room. So, if they're hearing other things that Shkreli might have said to the media, it makes it more likely that they're not going to be able to make an impartial decision based on the evidence.
>> The 34 year old gained notoriety when he raised the price of a life saving drug by 5000% as CEO of Turing Pharmaceuticals. But the charges he faces stem from his management of two hedge funds. Where prosecutors say he lied to investors and concealed huge trading losses. Which he then repaid with millions of dollars, allegedly stolen from another pharmaceutical company called Retrophin, where he was also CEO.
Shkreli was ousted from that company in 2014, he denies the charges against him.